Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2872-2020Class II

The OEC 9900 C-Arm is designed to provide fluoroscopic and spot-film images of the patient during diagnostic...

GE Healthcare / initiated 2020-05-08 / Open, Classified / root cause: manufacturing process

Ge Healthcare began a recall of The OEC 9900 C-Arm is designed to provide fluoroscopic and spot-film images of the patient during diagnostic, surgical and interventional procedures. Examples... on . FDA classified it as Class II and gives the reason as "GEHC Surgery became aware that some users of the 9800 and 9900 fluoroscopic mobile C-Arms (referred to as the system here on) within the United States had requested that a Field Service Engineer (FSE) change the dose...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2872-2020
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
GE Healthcare
Product
The OEC 9900 C-Arm is designed to provide fluoroscopic and spot-film images of the patient during diagnostic, surgical and interventional procedures. Examples of clinical application may include cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac, critical-care and emergency room procedures. The GE OEC 9800 is designed to provide fluoroscopic and spot-film imaging of the patient during diagnostic, surgical and interventional procedures. The system includes features specifically designed for use in diagnostic and interventional cardiac imaging procedures, and is also intended for cholangiography, endoscopic, urologic, orthopedic, neurologic, vascular, critical care and emergency room procedures.
Product code
RCC C-Arm Fluoroscopic X-Ray System
Reason for recall
GEHC Surgery became aware that some users of the 9800 and 9900 fluoroscopic mobile C-Arms (referred to as the system here on) within the United States had requested that a Field Service Engineer (FSE) change the dose value on the live update screen from AKR / CAK to DAP. All systems sold to customers in the US that leave GEHC Surgery (the place of manufacture) are configured to display AKR / CAK when they leave the factory. An FSE changing the dose display, per the customer request, to display DAP instead does not comply to 21CFR 1020.32(k), which requires fluoroscopic equipment manufactured on or after June 10, 2006 to display continuous updates of AKR and CAK values.
Root cause tag
manufacturing process
FDA root cause
Radiation Control for Health and Safety Act
Quantity in commerce
221
Distribution
Nationwide
Product codes and lots
OEC 9800, OEC 9900 Elite

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2872-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2872-2020Class IIOngoingFDA Mandated